Evaluation of serial erythrocyte sedimentation rate and C-reactive protein monitoring in infectious disease outpatient parenteral antimicrobial therapy patients.
Katarina Jackson, John J Veillette, Jared Olson, Allan M Seibert, Brandon J Webb
Author Information
Katarina Jackson: Department of Pharmacy, Intermountain Medical Center, Murray, UT, USA. ORCID
John J Veillette: Department of Pharmacy, Intermountain Medical Center, Murray, UT, USA. ORCID
Jared Olson: Department of Pharmacy, Primary Children's Hospital, Salt Lake City, UT, USA.
Allan M Seibert: Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, UT, USA. ORCID
Brandon J Webb: Division of Infectious Diseases and Clinical Epidemiology, Intermountain Health, Salt Lake City, UT, USA. ORCID
Of 313 patients whose outpatient parenteral antimicrobial therapy was managed by an ID physician, only 39 [12.5%, 95% CI (8.8%-16.1%)] had clinical decisions influenced by erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), or both. ESR/CRP ordering was associated with $530 in excess cost per treatment course (average duration 5.1 weeks) representing a diagnostic stewardship opportunity.
